BUSINESS● LOWAug 14 · Aug 14, 2026, 5:47 AM
Eton Pharmaceuticals forecasts 2026 revenue to exceed $145M while targeting adjusted EBITDA margin above 35%
Seeking Alpha Tech
Eton Pharmaceuticals projects its 2026 revenue to surpass $145 million, alongside an adjusted EBITDA margin target exceeding 35%. This outlines the company's financial expectations for the coming years.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS42m agoGold market consolidating rather than entering bear market, Metals Focus analyst saysSeeking Alpha TechBUSINESS43m agoCollegium resolves Nucynta patent dispute with GrünenthalSeeking Alpha Tech